Safeguard Your Ownership: Lab Equipment Debt Financing vs. Equity Financing

By Lauren Armstrong,
Marketing Director
Search
lab equipment debt financing

In the high-stakes world of biotech and diagnostics, the “burn rate” is a constant shadow. To hit your next clinical milestone or scale your testing throughput, you need high-end instrumentation—Mass Specs, HPLCs, or fermentation platforms.

But here’s the dilemma: Do you spend your hard-earned venture capital on depreciating hardware, or do you take on debt?

Choosing between lab equipment debt financing and equity financing isn’t just a CFO’s task; it’s a strategic decision that affects your runway and your ownership.

Let’s break down the mechanics of lab equipment debt financing so you can keep your lab running and your equity intact.

 

What is Lab Equipment Debt Financing?

Lab equipment debt financing is a strategic tool that allows laboratories to acquire essential scientific tools—from ICP-OES to flow cytometers—without a massive upfront cash drain.

Lab equipment debt financing is commonly used by startups, established laboratories, and medical facilities looking to expand capacity without depleting their cash reserves

At Bold View Capital, we structure these deals to cover 100% of the costs, including the “soft costs” that banks often ignore, like delivery, installation, and calibration.
Terms typically range from 2 to 7 years, with the equipment itself serving as the primary collateral. It’s a predictable monthly line item that keeps your cash in the bank for R&D and payroll.

 

woman tackling cash flow management

 

Why Do Biotech Startups Struggle Without Lab Equipment Financing?

Most early-stage biotech teams have the science nailed down, but lack the capital to buy instruments outright. A single analytical or bioprocessing system can cost more than a seed round’s operating budget, and the purchase usually lands before any revenue or grant money arrives.

Without opting for a financing alternative to a direct purchase, teams either delay experiments, send samples to a distant core facility and lose weeks in each cycle, or spend scarce equity on hardware that may be outdated before the first milestone.

 

What is Lab Equipment Equity Financing?

Equity financing is the process of selling a “slice” of your company to investors (VCs, angels, or private equity) in exchange for a lump sum of capital.
While this cash can certainly buy a $500k LC/MS, it comes at a steep price: permanent dilution. You aren’t paying interest, but you are giving away a percentage of your future exit.

A financed package can also cover the costs that surround the instrument itself. Examples include installation and site preparation, initial calibration and validation, and extended warranties or service plans. Consolidating these into one payment schedule keeps the lab from paying for them out of pocket in the weeks after delivery, when cash is often tightest.

 

Key Financing Types & Features

Understanding the “flavor” of your lab equipment debt financing is critical to matching it with your lab’s workflow:

  • Equipment Leasing (Operating Lease): Perfect for technology with high obsolescence rates. You get lower monthly payments and the flexibility to return, upgrade, or buy out the unit at Fair Market Value (FMV) at the end of the term.
  • Equipment Financing (Capital Lease): Think of this as a “rent-to-own” model. You get immediate ownership benefits with a nominal purchase fee (like $1) at the end of the term.
  • Sale-Leaseback: If you’ve already paid cash for your benchtop setup and realize you need that liquidity back, we buy the equipment from you and lease it back to you. It’s an instant infusion of non-dilutive capital.

 

Financing type Term length Ownership outcome Collateral Speed Flexibility
Equipment leasing (operating lease) Shorter than the equipment’s useful life Lessor keeps title; lab can return, upgrade, or buy at fair market value at term end The leased equipment Often the fastest to close High, especially for fast-changing technology
Equipment financing (capital lease / rent-to-own) Multi-year, generally aligned with useful life Lab takes ownership after a nominal purchase fee – typically $1 dollar. The financed equipment Moderate Moderate; fixed payment schedule
Sale-leaseback Multi-year lease back to the lab Equipment is sold to the funder and leased back; the lab regains title only if a repurchase option is included Equipment the lab already owns Moderate; requires ownership documents and an asset valuation Moderate; releases cash without new hardware

 

Why Buying Outright Creates Cash Flow Problems

A cash purchase converts a large part of the lab’s working capital into a single asset on day one. That asset starts depreciating immediately, and the money it consumed is no longer available for reagents, staff, trials, or the next round of experiments. For a company whose runway is measured in months, one large invoice can force a choice between buying the equipment and keeping the team fully funded through its next milestone.

Outright purchases also carry costs beyond the sticker price. Installation, validation, service contracts, and the risk that a platform becomes obsolete before it is paid off all land on the same balance sheet. Financing spreads these costs over the period in which the equipment is actually used, which lines the expense up with the work it supports.

 

Why Choose Lab Equipment Debt Financing Through a Company Like Bold View Capital?

For most scaling ventures, debt is the more efficient “fuel” for hardware.

  1. Cash Flow Optimization: Spread the cost of a Triple Quad across 60 months. This allows you to retain working capital for the things that actually drive valuation—like top-tier talent and clinical trials.
  2. Tax Advantages: In many jurisdictions, lease payments can be deducted as business expenses, lowering your overall tax liability.
  3. Avoid Obsolescence: Science moves fast. Leasing ensures you aren’t stuck with a decade-old analyzer when a more efficient model hits the market.
  4. Flexible Milestones: We can structure payments to match your reality—whether that’s a 90-day deferral while you wait for a grant or stepped payments that scale as your lab’s revenue grows.

 

lab equipment debt financing

 

The Reality of Equity Financing

Equity has its place, but using it for equipment is often the “most expensive” way to buy a microscope.

  • No Repayment Required: There is no monthly bill, which is a relief for pre-revenue startups.
  • Ownership Dilution: Every dollar of equity spent on a centrifuge is a dollar of your company you no longer own.
  • High Cost of Capital: Investors expect a 10x return. If you use $500k of equity to buy gear, you’re effectively “paying” $5M for that equipment upon exit.

 

Feature Lab Equipment Debt Financing Equity Financing
Ownership 100% Retention. You keep your cap table clean and your equity for future milestones. Dilution. You trade a permanent slice of your company for depreciating hardware.
Monthly Cost Predictable OpEx. A fixed monthly payment that fits into your burn rate. Zero. No monthly checks, which preserves immediate runway for pre-revenue labs.
Total Cost of Capital Low. You pay interest, but it’s a finite, tax-deductible expense. Extremely High. Investors expect a 10x return; that $500k instrument could “cost” $5M at exit.
Speed to Gear Fast. We underwrite based on the asset and the science. We move at startup speed. Slow. Months of due diligence, pitch decks, and legal hurdles.
Control Complete. You run your lab your way. No board seats required. Shared. Investors often demand board seats and a say in your strategic pivots.
Collateral The Instrument. Usually, the equipment itself (e.g., the LC/MS or HPLC) secures the deal. The Future. You are “collateralizing” the future potential of the entire enterprise.
Tax Impact Advantageous. Payments are often deductible as a business expense. None. Equity investments are not tax-deductible.

 

How to decide if lab equipment financing makes sense

Financing is not the right answer for every purchase. Four factors help separate the cases where it adds value from the cases where it adds cost.

  1. Cash runway after the purchase. If paying in full would leave the team with fewer than the months needed to reach the next funding or data milestone, financing protects the plan. If cash comfortably covers the purchase and the buffer, outright ownership may cost less overall.
  2. Useful life compared with technology change. Instruments that will be current for many years suit a multi-year financing term. Platforms that are likely to be superseded within a short window are often better placed on an operating lease, where the lab can upgrade at term end.
  3. Predictability of incoming cash. A fixed monthly payment works best when revenue, grant disbursements, or committed investment will reliably cover it. If those inflows are uncertain or lumpy, shorter terms or deferred-payment structures reduce the risk of default.
  4. Ownership and dilution priorities. Debt keeps the cap table intact but adds a required payment. Equity removes the payment but gives up a share of future value. Founders should weigh how much they are willing to dilute against how much they can carry in fixed monthly obligations.

 

How to Compare Lab Equipment Debt Financing Offers

Two offers for the same instrument can look similar on the first page and differ substantially in total cost and flexibility. A side-by-side review of the following six items usually makes the difference clear.

Rates. Ask whether the rate is fixed or variable, and whether it is quoted as an interest rate or as a factor that must be converted. Convert every offer to an annual percentage cost so they can be compared directly.

Term length. A longer term lowers the monthly payment but increases the total interest paid and can extend past the equipment’s useful life. Match the term to how long the instrument will remain productive for your work.

Down payment. Some structures require an upfront deposit, often equal to the first payment or a percentage of the equipment cost. A lower down payment preserves cash at closing, but confirm whether it is offset by a higher rate or a larger final payment.

Collateral. Determine whether the lender takes a lien on the equipment alone or also on other company assets. A blanket lien on all assets can constrain future borrowing, so it deserves the same scrutiny as the rate.

Service contracts. Check whether maintenance, calibration, or extended warranties are bundled into the payment, sold separately, or excluded. A bundled service plan can make the monthly figure look higher but may reduce unplanned downtime costs.

Deferred payments. Some lenders offer deferred or stepped payments that start low and rise over time, or delay the first payment until installation and validation are complete. These structures can help a lab that is still ramping up, but confirm how interest accrues during the deferral period.

 

lab equipment debt financing

Frequently Asked Questions

What is the downside of equity financing?

Beyond dilution, you lose control with equity financing. Investors often require board seats and have a say in your strategic direction. It’s also a grueling, months-long process compared to the speed of a lab equipment debt facility.

What are the benefits of equity financing?

Equity financing provides a “safety net.” Because there are no mandatory monthly payments, you don’t face the risk of default if a trial hits a snag or a grant is delayed.

Which is better, debt or equity financing?

It’s about the stage of the mission. Debt is superior for retaining ownership and lowering the long-term cost of capital if you have predictable (or pending) cash flow. Equity is better for high-risk, high-growth phases where you cannot afford any fixed monthly obligations.

How do I qualify for lab equipment debt financing?

We look at the whole picture. While we check credit scores and financial history (P&L, Balance Sheets), Bold View Capital also looks at your science. We understand the secondary market value of your LC/MS, which allows us to be more creative than a traditional bank.

Can refurbished be financed via lab equipment debt financing?

In many cases, yes. Lenders look at the instrument’s age, condition, make and model, service history, and the strength of its resale market. Well-maintained equipment from established manufacturers is generally easier to finance than older or niche platforms. Terms for used equipment are often shorter, and the amount financed may be lower than the purchase price, so the lender can be confident the collateral retains value.

What should I review in a financing quote?

Before signing, review the total of all payments over the full term, not just the monthly figure. Check for origination or documentation fees, the end-of-term buyout price, required insurance, late-payment and prepayment terms, and what happens if payments are missed. Confirm exactly what the quote includes, such as shipping, installation, calibration, and service coverage, and whether the rate is fixed for the full term. A clear written answer to each of these points is a reasonable request from any provider.

 

The Bold View Capital Bottom Line

Don’t trade your cap table for a lab bench. If you know your GC from your GC/MS, you deserve a partner who does, too.

Ready to scale your science without the dilution? Contact Bold View Capital today.

By Lauren Armstrong, 
Marketing Director
Share this article:

Related updates

financing sciex lc/ms/ms

Financing Sciex LC/MS/MS Fleets: 4 Strategic Capital Structures for Scaling Labs

Lab Equipment Leasing for Startups

Lab Equipment Leasing for Startups: 3 Ways to Predictably Budget for Science

lab equipment sale leasebacks for raising capital

Lab Equipment Sale Leasebacks: A Step-by-Step Guide